Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

BACKGROUND: We examined whether the use of erythropoiesis-stimulating agents (ESAs) to correct anemia at the predialysis stage could inhibit early-phase coronary events after hemodialysis initiation. METHODS: We enrolled 242 patients with chronic kidney disease who had received continued medical tre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cardiorenal Med
Päätekijät: Nishimura, Masato, Watanabe, Keitaro, Kitamura, Yuki, Nagashima, Takao, Tokoro, Toshiko, Takatani, Toru, Sato, Nodoka, Yamazaki, Satoru, Hashimoto, Tetsuya, Kobayashi, Hiroyuki, Ono, Toshihiko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2016
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159719/
https://ncbi.nlm.nih.gov/pubmed/27994599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448009
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia